Max Robotics — Global Service Robot Directory + US Certification

About

Zhenshun Li is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment. His work systematically evaluates the comparative efficacy of robotic versus laparoscopic gastrectomy, addressing a critical question in modern surgical oncology. In his landmark 2022 prospective cohort study, Li demonstrated that robotic total gastrectomy offers significant perioperative advantages over the laparoscopic approach, including reduced blood loss and faster recovery, while maintaining oncologic safety. This work, with 26 citations, has helped guide clinical decision-making in high-volume centers. Expanding on these findings, his 2024 systematic review and meta-analysis (20 citations) synthesizes global evidence to confirm that robotic gastrectomy achieves superior short-term outcomes without compromising survival. Li’s contributions are particularly impactful for surgeons adopting robotic platforms, as he provides rigorous, evidence-based comparisons that clarify the technology’s role in gastric cancer surgery. His research bridges the gap between technological innovation and clinical practice, offering clear guidance on when robotic systems meaningfully improve patient outcomes. Through these studies, Li has established himself as a key voice in the ongoing debate over optimal surgical approaches for gastric cancer.